Role of genomics and histology diagnosis in recurrent malignant pleural effusion
暂无分享,去创建一个
[1] M. Nowicki,et al. Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions , 2018, Journal of immunology research.
[2] H. Lee,et al. Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients , 2017, BMC Cancer.
[3] A. Fiorelli,et al. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in diagnosis of pleural effusion of malignant origin. , 2016, Interactive cardiovascular and thoracic surgery.
[4] Ko-Jiunn Liu,et al. Estrogen adversely affects the prognosis of patients with lung adenocarcinoma , 2014, Cancer science.
[5] Brennan C Kahan,et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score , 2014, Thorax.
[6] Ben Tran,et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. , 2014, Journal of the National Cancer Institute.
[7] A. Giatromanolaki,et al. Prognostic Factors in Patients Presenting with Pleural Effusion Revealing Malignancy , 2014, Respiration.
[8] F. Vargas,et al. Efficacy of two fluorescence in situ hybridization (FISH) probes for diagnosing malignant pleural effusions. , 2013, Lung cancer.
[9] M. Ried,et al. The treatment of pleural carcinosis with malignant pleural effusion. , 2013, Deutsches Arzteblatt international.
[10] E. Alkhalili,et al. Pleural Disease. , 2018, The New England journal of medicine.